Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PFE

Pfizer Inc

27.79

Aug 20 • 3:59 PM ET -0.45 (-1.59%)

27.75

Aftermarket • 7:59 PM ET -0.04 (-0.14%)

Healthcare Drug Manufacturers - General USA Large NYSE

Aug 19, 1:02 PMMerck-Moderna mRNA cancer vaccine data sparks sector rally lifting Pfizer 3%

Peers: MRK LLY JNJ ABBV AZN BMY NVS AMGN SNY GSK

| Held by: VTI VOO IVV SPY VTV XLV HDV VYM DVY FDL

Index	S&P 500
Market Cap	158.39B
Enterprise Value	210.19B
Income	4.33B
Sales	63.70B
Book/sh	14.95
Cash/sh	2.05
Dividend Est.	1.72 (6.20%)
Dividend TTM	1.72 (6.19%)
Dividend Ex-Date	Jul 24, 2026
Dividend Gr. 3/5Y	2.23% 2.37%
Payout	126.85%
Employees	75000
IPO	Jan 17, 1944

P/E	36.80
Forward P/E	9.61
PEG	-
P/S	2.49
P/B	1.86
P/C	13.54
P/FCF	14.42
EV/EBITDA	8.94
EV/Sales	3.30
Quick Ratio	0.96
Current Ratio	1.27
Debt/Eq	0.74
LT Debt/Eq	0.71
Option/Short	Yes / Yes

EPS (ttm)	0.76
EPS next Y	2.89
EPS next Q	0.76
EPS this Y	-7.64%
EPS next Y	-2.72%
EPS next 5Y	-8.25%
EPS past 3/5Y	-37.19% -3.57%
Sales past 3/5Y	-14.56% 8.48%
EPS Y/Y TTM	-59.71%
Sales Y/Y TTM	-0.21%
EPS Q/Q	-108.60%
Sales Q/Q	2.60%
Earnings	Aug 04 BMO
EPS/Sales Surpr.	12.87% 4.41%

Insider Own	0.09%
Insider Trans	2.18%
Inst Own	68.56%
Inst Trans	-0.23%
ROA	2.13%
ROE	4.99%
ROIC	2.97%
Gross Margin	64.83%
Oper. Margin	26.57%
Profit Margin	6.80%
SMA20	6.38%
SMA50	9.79%
SMA200	6.98%
Trades

Shs Outstand	5.70B
Shs Float	5.69B
Short Float	2.84%
Short Ratio	3.83
Short Interest	161.48M
52W High	28.75 -3.32%
52W Low	23.58 17.85%
Volatility	1.94% 1.98%
ATR (14)	0.59
RSI (14)	68.35
Beta	0.30
Rel Volume	0.70
Avg Volume	42.13M
Volume	29,297,070

Perf Week	3.69%
Perf Month	11.97%
Perf Quarter	7.75%
Perf Half Y	3.46%
Perf YTD	11.61%
Perf Year	9.50%
Perf 3Y	-24.20%
Perf 5Y	-42.96%
Perf 10Y	-16.17%
Recom	2.55
Target Price	28.28
Prev Close	28.24
Price	27.79
Change %	-1.59%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-06-26	Downgrade	HSBC Securities	Buy → Hold	$28
Jun-10-26	Upgrade	RBC Capital Mkts	Underperform → Sector Perform	$25
Mar-02-26	Upgrade	Argus	Hold → Buy	$35
Feb-25-26	Initiated	RBC Capital Mkts	Underperform	$25
Feb-20-26	Initiated	Barclays	Underweight	$25
Feb-12-26	Downgrade	Daiwa Securities	Outperform → Neutral	$27
Jan-07-26	Resumed	UBS	Neutral	$25
Dec-02-25	Resumed	Citigroup	Neutral	$26
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$30
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39

Show Previous Ratings

Aug-20-26 02:21PM	Moderna's Melanoma Result Landed On A Market Positioned The Other Way (Trefis)
01:27PM	Merck Stock Ran On A Checklist Published In Advance (Trefis)
12:54PM	Pfizer Stock Is A Race Between New Drugs And Old Patents (Trefis)
10:58AM	What Moderna & Merck's cancer vaccine breakthrough means for healthcare stocks (Yahoo Finance Video)
05:59AM	Why Is Merck Stock Still Undervalued After An 80% Surge? (Trefis)
04:08PM	Loading…
Aug-19-26 04:08PM	Johnson & Johnson Stock Runs On A Calendar The Market Does Not Set (Trefis)
03:40PM	Is AbbVie Stock About To Break Out Again? (Trefis)
02:54PM	BioNTech Stock Surges 20% on Moderna Cancer Vaccine Win. Why the Gains Could Fade. (Barrons.com)
01:02PM	Why 2026 Is Biotech's Comeback Year (Barrons.com)
12:00PM	Flash Heard: Why Healthcare Is Partying Like It's Late 2020 (The Wall Street Journal)
11:15AM	Insider Watch: 3 CEOs Betting Millions on Their Own Stocks (Zacks)
06:30AM	HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation (TMX Newsfile)
05:24AM	Obesity investings way forward, mapped (Pitchbook)
Aug-18-26 10:27AM	Nike Stock Hits Lowest Level Since 2014 as Turnaround Drags On (Barrons.com)
Aug-17-26 05:29PM	Why Isn't Eli Lilly Stock Trading At The Top Of Its Peer Group? (Trefis)
12:11PM	Loading…
12:11PM	Fulcrum Therapeutics & Slate Medicines Merge for Next-Generation Migraine Therapies (Exec Edge)
11:28AM	What The Headline Growth Rate Hides About JNJ Stock (Trefis)
06:07AM	EMA validates Pfizer and Valneva's Lyme disease vaccine (Pharmaceutical Business Review)
Aug-14-26 05:22PM	AbbVie Defends Its Turf, But Leaves One Big Question Open (Trefis)
01:45PM	Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase (Barrons.com)
11:54AM	Why Did VALN Stock Surge 24% Today? (Stocktwits)
04:59AM	BioNTechs oncology pivot comes with a new CEO (Pharma Voice)
01:00AM	Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency (Business Wire)
Aug-13-26 12:10PM	The Sharpest Exchanges From ABBV's Earnings Call (Trefis)
08:20AM	Pfizer CEO Buys $1 Million of Stock (GuruFocus.com)
01:01AM	Spero Therapeutics Inc (SPRO) (Q2 2026) Earnings Call Highlights: FDA Approval of Utebzi and ... (GuruFocus.com)
Aug-12-26 04:49PM	How ABBV Stock Moved Away From Its Peer Group (Trefis)
03:17PM	Amgen Stock And The Price Of A Promise (Trefis)
Aug-11-26 07:09PM	JNJ Keeps Climbing. Should You Climb On? (Trefis)
05:38PM	$49 Billion In Payouts, A Lagging Stock: The PFE Trade-Off (Trefis)
02:09PM	Loading…
02:09PM	Pfizer agrees to $44M Chantix settlement. See if you qualify (USA TODAY)
Aug-10-26 07:01PM	What Analysts Really Pressed LLY On This Quarter (Trefis)
12:01PM	Eli Lilly Stock's Next Climb Runs Through A Pill, Not Just An Injection (Trefis)
Aug-07-26 02:38PM	The Two Divergent Paths Priced Into Eli Lilly Stock (Trefis)
Aug-06-26 07:19PM	Novavax Inc (NVAX) (Q2 2026) Earnings Call Highlights: Matrix-M Momentum Drives Revenue ... (GuruFocus.com)
05:29PM	NVAX Stock Holds Steady As Novavax Lifts Revenue Outlook On Licensing Pivot Retail Eyes Buyout, More Partnership Deals (Stocktwits)
Aug-05-26 05:23PM	Why PFE Stock Hands You So Much Cash Right Now (Trefis)
11:04AM	Pfizer Stock Slips Despite Earnings Beat and $2.5 Billion Cuts (GuruFocus.com)
07:00AM	Earnings roundup: Gileads uncertain future, Pfizers crossroads and Mercks PCSK9 launch (BioPharma Dive)
01:17AM	Pfizer, Merck, Amgen Double Down On Cancer And Send Takeover Buzz Around SLS And IBRX Into Overdrive (Stocktwits)
Aug-04-26 06:50PM	Pfizer Inc. Q2 2026 Earnings Call Summary (Moby)
03:55PM	Pfizer Earnings Reveal New Engine Beyond Covid (GuruFocus.com)
03:23PM	The $85 Billion Consolation Prize For JNJ Shareholders (Trefis)
12:29PM	Pfizer repels Covid-19 sales tumble to raise 2026 guidance (Pharmaceutical Technology)
11:23AM	Pfizer's Recovery Story Is Starting to Look More Durable (GuruFocus.com)
10:26AM	Pfizer raises revenue outlook after quarterly earnings top estimates (Proactive)
09:49AM	Pfizer Raises Revenue Outlook as Eliquis Sales Drive Strong Quarter (InvestorsHub)
09:05AM	Pfizer Hikes 2026 Sales Outlook By $500 Million On Second-Quarter Beat (Investor's Business Daily)
08:55AM	NYSE Content Update: ADI to Make NYSE Trading Debut After Spin-Off (PR Newswire)
08:06AM	Pfizer Q2 earnings on deck: What to expect (GuruFocus.com)
07:53AM	AstraZeneca-Bristol Myers: The Floodgates for Biotech Mergers Are Open (Barrons.com)
07:40AM	Pfizer posted stronger earnings than expected and raised its revenue outlook (Quartz)
07:39AM	Pfizer Q2 2026 earnings beat, revenue guidance raised (Quartz)
07:24AM	Pfizer Post Loss on Higher Revenue (The Wall Street Journal)
07:12AM	Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings (Barrons.com)
06:58AM	Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis (Reuters)
06:58AM	Pfizer: Q2 Earnings Snapshot (Associated Press)
06:45AM	Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance (Business Wire)
04:51AM	SpaceX and Advanced Micro headline Tuesday's earnings slate (MarketWatch)
03:48AM	Stock Market Today: Dow, S&P 500 and Nasdaq set to see rally continue following big tech gains; oil prices climb on report of ship being struck in Strait of Hormuz; SpaceX earnings on tap. (MarketWatch)
Aug-03-26 07:14PM	$49 Billion In Payouts, A Lagging Stock: The Pfizer Trade-Off (Trefis)
05:05PM	AbbVie's Growth Now Leans On A Single Molecule (Trefis)
09:08AM	Medicus Pharma CMO to lead Antev's Teverelix clinical programme (Proactive)
Aug-02-26 10:48PM	Biotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure? (Stocktwits)
Jul-31-26 10:26AM	The Signs Before Eli Lilly Stock Surged Were All On The Record (Trefis)
10:07AM	LLY Stock: Collect 12% Now, In Exchange For Capping Upside At 15% (Trefis)
07:06AM	Sanofi to rebuild trust with Regeneron; Apnimed adds to string of upsized biotech IPOs (BioPharma Dive)
01:00AM	Here Comes the Next Wave of GLP-1s. They'll Treat a Lot More Than Obesity. (Barrons.com)
Jul-30-26 12:12PM	Alnylam plunges as earnings deliver one-two punch (BioPharma Dive)
11:05AM	EU regulatory roundup: AbbVie, Pfizer & BioNTech and Incyte net approvals (Pharmaceutical Technology)
08:40AM	EU greenlights Pfizer and BioNTech's new COVID vaccine (InvestorsHub)
08:17AM	Bristol Myers Squibb raises 2026 forecast after Q2 earnings beat (Quartz)
06:59AM	Bristol Myers Raises Earnings Guidance as Newer Drugs Drive Big Quarterly Beat (Barrons.com)
06:45AM	Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo (Business Wire)
Jul-29-26 04:30PM	European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union (Business Wire)
03:27PM	The Week Ahead: Jobs Data, Top 10 Earnings Reports to Watch (Schaeffer's Research)
02:11PM	The Real Price of AbbVie Stock Is Cheaper Than You Think (Trefis)
Jul-28-26 04:52PM	What Johnson & Johnson Stock Told You Before It Surged (Trefis)
04:41PM	Does Eli Lilly Stock Actually Diversify Your Portfolio? (Trefis)
01:01AM	OPKO Health Inc (OPK) Q2 2026 Earnings Call Highlights: Strong Pharmaceutical Growth and ... (GuruFocus.com)
Jul-27-26 03:54PM	The Engine Behind ABBV Stock Has Real Parts (Trefis)
02:33PM	Collect 9.8% On LLY Stock Now, Own It 30% Cheaper If It Dips (Trefis)
02:50AM	Johnson & Johnson Now Leads Its Pitch With An Oncology Bet (Trefis)
Jul-26-26 10:00AM	Traders Are Getting a New Tool to Wager on the Biggest US Stocks (Bloomberg)
Jul-25-26 10:30AM	Johnson & Johnson Is Becoming A Narrower Company Than You Bought (Trefis)
Jul-22-26 04:30PM	FDA Grants Priority Review for Pfizers TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer (Business Wire)
10:10AM	Trump Takes Another Swing at Drug Industry in Made-in-USA Push (Bloomberg)
09:17AM	LLY Has Momentum. The Question Is The Price (Trefis)
Jul-21-26 04:04PM	Eli Lilly Stock And The Price Of Confidence (Trefis)
02:31PM	AbbVie Stock Zigs When The Market Zags (Trefis)
Jul-20-26 02:55PM	Reading Between The Lines Of JNJ Stock's Latest Call (Trefis)
01:45PM	Eli Lilly Stock And The Price Of Confidence (Trefis)
08:17AM	Merck's Keytruda Faces a Patent Cliff. These New Cancer Drugs Could Take Over. (Barrons.com)
Jul-17-26 05:51PM	The Real Question Buried Inside Merck Stock's Premium Price (Trefis)
06:07AM	Arbutus, Sanofi escalate mRNA patent fights; InnoCares TYK2 contender advances (BioPharma Dive)
Jul-16-26 02:41PM	ABUS Stock On Track For Best Day In About Two Months Whats The Moderna Connection? (Stocktwits)
09:19AM	What Could Push LLY Stock Higher From Here? (Trefis)
09:19AM	The Real Engine Behind Johnson & Johnson Stock's Next Climb (Trefis)
08:44AM	Why Is The Market Punishing JNJ Stock? (Trefis)
Jul-15-26 11:59PM	MetroLoft Leads $104M Office-to-Residential Bet in FiDi (CRE Daily)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Ph.D.Dr. Albert Bourla D.V.M.

Executive VP & CFOMr. David M. Denton

M.D.Dr. Chris Boshoff FMedSci

Executive VP & Chief Legal OfficerMr. Douglas M. Lankler

Executive VP & Chief U.S. Commercial OfficerMr. Aamir Malik

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOURLA ALBERT	Chairman & CEO	Aug 12 '26	Buy	26.34	38,000	1,000,920	429,173	Aug 12 04:04 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 05 '26	Sale	25.40	3,278	83,261	28,611	Aug 06 11:26 AM
BLAYLOCK RONALD E	Director	Aug 05 '26	Buy	25.46	39,231	998,821	66,938	Aug 05 04:03 PM
Buckley Mortimer J	Director	Aug 05 '26	Buy	25.52	37,632	960,369	37,632	Aug 05 04:02 PM
DAMICO JENNIFER B.	SVP & Controller	Jun 09 '26	Sale	25.70	2,000	51,400	31,397	Jun 10 07:58 PM
SAHNI PAYAL	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	82,816	Feb 27 06:35 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 25 '26	Option Exercise	33.82	122,907	4,156,715	282,186	Feb 27 06:35 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 25 '26	Option Exercise	33.82	17,558	593,812	29,744	Feb 27 06:35 PM
BOURLA ALBERT	Chairman & CEO	Feb 25 '26	Option Exercise	33.82	491,626	16,626,791	864,215	Feb 27 06:34 PM
Fonseca Lidia	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	101,579	Feb 27 06:34 PM
McDermott Michael	Executive Vice President	Feb 25 '26	Option Exercise	33.82	37,925	1,282,624	114,534	Feb 27 06:34 PM

Open in Screener

KMX

Carmax Inc

61.05

Aug 20 • 4:00 PM ET +2.10 (3.56%)

61.50

Aftermarket • 7:58 PM ET +0.45 (0.74%)

Consumer Cyclical Auto & Truck Dealerships USA Mid NYSE

Peers: CVNA AN CARG LAD GPI PAG SAH LKQ AAP AZO

| Held by: IJR VTI VB AVUV VBR VXF SPSM IJS SLYV RWJ

Index	-
Market Cap	8.66B
Enterprise Value	26.77B
Income	222.54M
Sales	28.19B
Book/sh	43.12
Cash/sh	5.13
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	27796
IPO	Feb 04, 1997

P/E	40.18
Forward P/E	-
PEG	-
P/S	0.31
P/B	1.42
P/C	11.91
P/FCF	8.71
EV/EBITDA	27.93
EV/Sales	0.95
Quick Ratio	0.82
Current Ratio	2.70
Debt/Eq	3.08
LT Debt/Eq	2.97
Option/Short	Yes / Yes

EPS (ttm)	1.52
EPS next Y	-
EPS next Q	0.72
EPS this Y	-6.95%
EPS next Y	-
EPS next 5Y	1.03%
EPS past 3/5Y	-17.96% -18.02%
Sales past 3/5Y	-3.76% 6.67%
EPS Y/Y TTM	-58.01%
Sales Y/Y TTM	-1.69%
EPS Q/Q	-5.27%
Sales Q/Q	5.51%
Earnings	Jun 17 BMO
EPS/Sales Surpr.	35.71% 7.94%

Insider Own	2.04%
Insider Trans	0.84%
Inst Own	102.98%
Inst Trans	-3.68%
ROA	0.82%
ROE	3.59%
ROIC	0.92%
Gross Margin	10.68%
Oper. Margin	2.06%
Profit Margin	0.79%
SMA20	4.26%
SMA50	10.27%
SMA200	36.31%
Trades

Shs Outstand	141.91M
Shs Float	139.02M
Short Float	9.92%
Short Ratio	4.46
Short Interest	13.80M
52W High	62.56 -2.42%
52W Low	30.26 101.75%
Volatility	3.86% 3.43%
ATR (14)	2.15
RSI (14)	63.28
Beta	1.17
Rel Volume	0.84
Avg Volume	3.09M
Volume	2,613,171

Perf Week	1.67%
Perf Month	6.27%
Perf Quarter	63.54%
Perf Half Y	36.94%
Perf YTD	58.00%
Perf Year	5.60%
Perf 3Y	-25.99%
Perf 5Y	-51.07%
Perf 10Y	2.95%
Recom	2.75
Target Price	51.42
Prev Close	58.95
Price	61.05
Change %	3.56%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-29-26	Upgrade	JP Morgan	Underweight → Neutral	$60
Jul-21-26	Upgrade	Barclays	Underweight → Equal Weight	$61
Jun-18-26	Upgrade	Stephens	Equal-Weight → Overweight	$66
May-27-26	Initiated	UBS	Neutral	$42
Apr-15-26	Resumed	BofA Securities	Underperform	$40
Nov-12-25	Initiated	Barclays	Underweight	$28
Nov-10-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$35
Nov-07-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Nov-07-25	Downgrade	Needham	Buy → Hold
Nov-06-25	Downgrade	William Blair	Outperform → Mkt Perform
Nov-06-25	Downgrade	The Benchmark Company	Buy → Hold
Nov-06-25	Downgrade	JP Morgan	Neutral → Underweight	$30
Oct-07-25	Downgrade	Stephens	Overweight → Equal-Weight	$42
Sep-29-25	Downgrade	Seaport Research Partners	Buy → Neutral
Sep-26-25	Downgrade	Oppenheimer	Outperform → Perform
Sep-26-25	Downgrade	Evercore ISI	Outperform → In-line	$52
Sep-25-25	Downgrade	Wedbush	Outperform → Neutral
Aug-06-25	Upgrade	JP Morgan	Underweight → Neutral	$58
Jul-17-25	Initiated	The Benchmark Company	Buy	$75
Jul-01-25	Resumed	Morgan Stanley	Overweight	$80

Show Previous Ratings

Aug-12-26 09:45AM	CarMax Named one of the 2026 PEOPLE Companies That Care (GlobeNewswire)
Aug-06-26 09:36PM	The Takeover Case for OPLN: A Digital Powerhouse Hiding in Plain Sight (Trefis)
09:30AM	CarMax Teams with Sierra to Enhance Inbound Sales Call Experience (GlobeNewswire)
Aug-05-26 12:23PM	Starboard Value Has Taken New Position in Shake Shack (Bloomberg)
Jul-29-26 05:16PM	JPMorgan Delivers Major CarMax Stock Reset (GuruFocus.com)
12:43PM	Loading…
Jul-02-26 12:43PM	CarMax's Turnaround Is a Work in Progress, but Insiders Are Buying Anyway (Barrons.com)
Jun-30-26 10:00AM	CarMax Recognized as One of the 50 Most Community-Minded Companies in the US (GlobeNewswire)
Jun-26-26 07:00AM	For CarMax, lower profits are part of its short-term growth strategy (Wards Auto)
Jun-18-26 06:54PM	The Price Of A CarMax Sales Beat (Trefis) +13.14%
01:29PM	KMX Stock Recoups Earnings Day Losses Analysts Pour Praise On New CarMax CEOs Focus On Cost And Customer Experience (Stocktwits)
09:02AM	CarMax Q1 FY2027 earnings beat: Keith Barr unveils growth strategy (Quartz)
09:02AM	CarMax beat earnings estimates but is facing falling used-car margins as new CEO unveils growth strategy (Quartz)
Jun-17-26 04:43PM	CarMax Earnings Fall Far Less Than Feared, But Shares Sink (Investor's Business Daily) -8.98%
03:01PM	KMX Stock Slides Nearly 9% CarMax CEO Flags Operational Challenges, Says Costs Are Too High (Stocktwits)
03:00PM	CarMax Inc (KMX) Q1 2027 Earnings Call Highlights: Strong Sales Growth Amidst Profitability ... (GuruFocus.com)
11:09AM	Loading…
11:09AM	?? Under the Radar: CarMax Stock Slides as CEO Flags Challenges (The Wall Street Journal)
10:34AM	CarMax shares drop as margin pressure overshadows strong quarterly results (Proactive)
10:12AM	Options Traders Circle CarMax Stock After Post-Earnings Pivot (Schaeffer's Research)
08:45AM	CarMax Tops Expectations as Growth Plan Gains Momentum (KMX) (InvestorsHub)
06:48AM	CarMax beats estimates as new strategy drives early results (Investing.com)
06:38AM	CarMax Profit Falls Despite Higher Sales (The Wall Street Journal)
06:37AM	CarMax Stock Rises. Used-Car Retailer Tops Earnings Estimates. (Barrons.com)
06:05AM	CarMax: Fiscal Q1 Earnings Snapshot (Associated Press)
05:50AM	CarMax Reports First Quarter Fiscal 2027 Results (Business Wire)
Jun-14-26 02:00PM	The FOMC Meeting, Retail Sales Data, Kroger Earnings, and More to Watch This Week (Barrons.com)
May-28-26 05:00PM	CarMax Announces First Quarter Conference Call and Annual Meeting Information (Business Wire)
May-27-26 09:35AM	FedEx upgraded, Dollar General downgraded: Wall Street's top analyst calls (The Fly)
May-12-26 04:40PM	CarMax Announces Robert O'Shaughnessy to Join Board of Directors (Business Wire)
May-08-26 10:43AM	Will Carvana Continue To Rally Post Stock Split? (Trefis)
Apr-17-26 08:13AM	CarMax prices start to fall as turnaround plan begins (Wards Auto)
09:47AM	Loading…
Apr-15-26 09:47AM	Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls (The Fly)
08:00AM	CarMax cut its prices to bring back buyers. It just reported a $121 million loss (Moneywise)
03:01AM	CarMax Inc (KMX) Q4 2026 Earnings Call Highlights: Navigating Challenges with Strategic Adjustments (GuruFocus.com)
Apr-14-26 04:46PM	CarMax, Inc. Q4 2026 Earnings Call Summary (Moby) -15.12%
02:10PM	Tesla stock upgraded, CarMax Q4 earnings disappoint Wall Street (Yahoo Finance Video)
01:23PM	Why CarMax Stock Is Sinking Despite Earnings Beat (Investor's Business Daily)
12:44PM	CarMax Shares Drop 12% As Profit Per Vehicle Set To Decline (GuruFocus.com)
11:11AM	CarMax Drops as Investors Underwhelmed by Revival Strategy (Bloomberg)
07:32AM	CarMax beats FQ4 forecasts, flags $141mn goodwill charge; shares dip (Investing.com)
07:23AM	CarMax Swings to Loss After Cutting Prices to Bring Back Shoppers (The Wall Street Journal)
07:09AM	CarMax: Fiscal Q4 Earnings Snapshot (Associated Press)
07:04AM	CarMax Stock Sinks After Earnings. New CEO Has Work to Do. (Barrons.com)
06:50AM	CarMax Reports Fourth Quarter and Fiscal Year 2026 Results (Business Wire)
06:00AM	Morning Brief: Goldman rakes it in, but issues a warning (Yahoo Finance)
04:57AM	JPMorgan, Citi and Wells Fargo deliver results as earnings season gathers speed (MarketWatch)
04:11AM	Stock Market Today: Dow, S&P 500 and Nasdaq set to hold near record highs as earnings season ramps up with JPMorgan results on tap (MarketWatch)
Apr-09-26 04:51PM	CarMax Will Add Two Board Members After Talks With Activist Investor Starboard (The Wall Street Journal)
04:15PM	CarMax Announces William Cobb and Jim Kessler to Join the Board (Business Wire)
Apr-06-26 11:16AM	Carvana Stock Doubled Last Year. Why This Analyst Isn't Bullish Anymore. (Barrons.com)
Apr-01-26 09:30AM	CARMAX CELEBRATES 22nd CONSECUTIVE YEAR AS ONE OF FORTUNE MAGAZINE'S 100 BEST COMPANIES TO WORK FOR (GlobeNewswire)
Mar-27-26 07:15AM	New CarMax CEO Barr looks to tech for better UX (Wards Auto)
Mar-26-26 04:37PM	Stock traders are wary of this market - and retail investors should be too (MarketWatch)
Mar-19-26 05:00PM	CarMax Announces Fourth Quarter Conference Call (Business Wire)
04:12PM	These charts suggest the bears aren't done with the stock market yet (MarketWatch)
Mar-18-26 11:45AM	CarMax appoints Keith Barr as CEO (Wards Auto)
Mar-13-26 08:44PM	Oracle Has More Resilience Amid AI Pressures, Says Analyst. Plus, CarMax, Rivian, and More Stocks. (Barrons.com)
Mar-12-26 06:40PM	The S&P 500 just broke a major support. Another 10% decline is likely. (MarketWatch)
Mar-11-26 04:20PM	Investor Starboard Sees CarMax Upside as Barr Takes Helm (Transport Topics)
02:30PM	Starboard Builds $350 Million Stake in CarMax, Seeks Board Seats (GuruFocus.com)
01:40PM	Starboard Takes $350 Million CarMax Stake, Seeks Board Seats (Bloomberg)
01:01PM	An Important Investor Has an Idea for CarMax: Charge Less for Used Cars (Investopedia)
11:29AM	Falling prices steer US buyers toward used electric vehicles (Reuters)
10:35AM	CarMax Issues Statement on Engagement With Starboard Value (Business Wire)
09:58AM	CarMax Stock Edges Higher as Activist Takes Stake, Says New CEO Must 'Move Quickly' (Barrons.com)
09:34AM	Activist Starboard Pushes for Change at CarMax (The Wall Street Journal)
09:17AM	CarMax Stock: Auto Business Activist Investor Takes Stake (Investor's Business Daily)
08:00AM	Starboard Delivers Letter to CarMax (Business Wire)
Mar-06-26 10:02AM	Will Carvana's Fixed Cost Leverage Drive Its EBITDA Margin? (Zacks)
09:52AM	Will Vertical Integration Strengthen Carvana's Prospects? (Zacks)
Mar-05-26 08:03AM	Carvana's Rough Start to 2026 Post Stellar 2025: How to Play the Stock (Zacks)
Mar-04-26 08:10AM	GM merging its CPO dealer sales program with CarBravo (Wards Auto)
Mar-03-26 09:40AM	Should Value Investors Buy CarMax (KMX) Stock? (Zacks)
Feb-27-26 10:36AM	CarMax Launches First-of-Its-Kind Car Shopping and Selling Experience in ChatGPT App Store (GlobeNewswire)
Feb-26-26 10:33PM	Q4 Earnings Recap: CarMax (NYSE:KMX) Tops Vehicle Retailer Stocks (StockStory)
Feb-25-26 10:10AM	Trump Trade: FedEx files suit to recoup tariff duties (TipRanks)
Feb-23-26 07:45PM	CarMax to pay $420K to resolve DOJ allegations over servicemember vehicle repossessions (Fox Business)
Feb-19-26 08:12PM	CarGurus Q4 Earnings Call Highlights (MarketBeat)
Feb-18-26 12:25PM	Why Is CarMax (KMX) Stock Soaring Today (StockStory) +8.05%
Feb-14-26 02:26PM	Carvana Drops 15% This Week: Heres The 3 Biggest Storylines (24/7 Wall St.)
Feb-13-26 08:56AM	$1 Billion Accounting Questions Cloud Carvanas 44% Sales Surge (24/7 Wall St.)
Feb-12-26 09:43AM	CarMax Taps Former Hotel CEO Keith Barr After Sales Slump (Transport Topics) -10.57%
09:00AM	Wallace Weitz Exits CarMax Inc, Impacting Portfolio by -1.58% (GuruFocus.com)
09:00AM	Eclipse backs all-EV marketplace Ever in $31M funding round (TechCrunch)
07:36AM	CarMax Names a New CEO. He's Not a Car Guy. (Barrons.com)
06:50AM	CarMax Names Keith Barr as Chief Executive Officer (Business Wire)
06:20AM	CarMax Taps Hotel Veteran to Lead Turnaround (The Wall Street Journal)
Feb-08-26 11:41PM	1 Safe-and-Steady Stock Worth Investigating and 2 We Question (StockStory)
Feb-04-26 07:30AM	CarMax Named One of TIME's America's Most Iconic Companies (GlobeNewswire)
05:44AM	CarMax, Inc. (KMX) Turns to Pricing and Marketing Actions to Revitalize Sales (Insider Monkey)
Feb-03-26 11:35PM	1 Profitable Stock to Target This Week and 2 We Turn Down (StockStory)
Jan-30-26 09:24AM	Giverny Capital Asset Management Exited Its Long-Term Holding CarMax (KMX) in 2025 (Insider Monkey)
Jan-23-26 08:56AM	Should You Hold CarMax (KMX)? (Insider Monkey)
Jan-14-26 07:50AM	CarGurus Pivots Beyond Marketplace at Needham Conference, Ramping AI and Dealer Software Push (MarketBeat)
Jan-13-26 11:05PM	3 Reasons KMX is Risky and 1 Stock to Buy Instead (StockStory)
Jan-12-26 11:43AM	Why CarMax Stock Slipped 53% In 2025 (Motley Fool)
Jan-07-26 05:59AM	CarMax promises price relief for used-car customers (Wards Auto) +5.35%
Dec-31-25 09:51AM	Here's Why You Should Offload CarMax Stock From Your Portfolio (Zacks)
Dec-26-25 09:16AM	Can Carvana Stock Extend Its Strong 2025 Rally Into 2026? (Zacks)
Dec-25-25 12:31AM	The 5 Most Interesting Analyst Questions From CarMax's Q4 Earnings Call (StockStory)
Dec-22-25 08:59AM	Bear of the Day: CarMax (KMX) (Zacks)

CarMax, Inc.is a holding company, which engages in the retail sale of used vehicles and wholesale vehicle sales. It operates through the following segments: CarMax Sales Operations, and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of retail sales of used vehicles, wholesale vehicle sales, related products and services, vehicle repair services, and financing arrangements. The CAF segment consists of its finance operation, which provides financing to customers purchasing retail vehicles from CarMax. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Executive VPMr. Enrique N. Mayor-Mora

Executive VP & COOMr. Charles Joseph Wilson

Executive VP and Chief Information & Technology OfficerMr. Shamim Mohammad CPA

Executive VPMs. Diane Long Cafritz J.D.

CEOMr. Keith Barr

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chawla Sona	Director	Jun 25 '26	Buy	53.39	2,000	106,780	21,702	Jun 26 04:13 PM
Shinder Marcella	Director	Jun 25 '26	Buy	52.01	574	29,854	24,993	Jun 26 04:13 PM
ONeil Mark F	Director	Jun 24 '26	Buy	52.36	4,800	251,328	4,800	Jun 26 04:13 PM
ONeil Mark F	Director	Jun 24 '26	Buy	52.36	4,800	251,328	29,490	Jun 26 04:13 PM
FOLLIARD THOMAS J	Director	Jun 23 '26	Option Exercise	51.91	14,855	771,123	227,676	Jun 24 05:21 PM
Bensen Peter J	Director	Jun 22 '26	Buy	52.20	2,500	130,500	24,796	Jun 24 05:21 PM
Barr Keith	President and CEO	Jun 22 '26	Buy	53.01	9,400	498,247	33,375	Jun 24 05:20 PM
McCreight David W.	Director	Mar 16 '26	Option Exercise	41.71	30,558	1,274,574	47,257	Mar 18 04:11 PM
ONeil Mark F	Director	Oct 02 '25	Buy	46.21	10,816	499,807	24,690	Oct 06 04:11 PM
STEENROD MITCHELL D	Director	Oct 02 '25	Buy	45.57	2,000	91,140	38,330	Oct 03 04:09 PM

PFE

Pfizer Inc

KMX

Carmax Inc

Upgrade your Finviz experience